BASF SE (BAS.DE) analysis

Loading the Vaultflake…

Health is the debt of several chemical books, not of a system that cannot be copied. Quality separates the standard-product margin from the specialty. Growth follows volumes sold, not a year of cheap energy. P/E is read against a year of expensive energy, not against that year as normal. Shareholder return is the dividend, checked against cash. Do not read it as the largest chemical company already measured.

The P/E of a year of expensive energy is not the earnings if the buyer leaves. EV/EBITDA is read with the idle plant inside. Do not use a single-book chemical multiple as if the standard product and the specialty were the same. A dash if BAS.DE is missing.

Limits of this report

Not advice on BASF. Vaultflake does not treat the group as the largest and does not describe the chemistry. Read the filings. A past dividend is not a right. The table is a snapshot, not a target price.

Questions from this report